“There are 10,000 baby boomers entering Medicare every day… If you could delay the onset of Alzheimer’s by five years, you’d save Medicare $50 billion a year. That’s what biotechnology companies do.” ~Jim Greenwood James Greenwood, President & CEO of the Biotechnology Industry Organization (BIO) gave the keynote speech at the BioOhio conference yesterday outlining […]
OK, maybe not explode but at least some terrible, Armageddon-like fate. According to a study by the Federal Trade Commission, pharmaceutical companies are engaging in anti-competitive tactics of paying potential generic rivals to delay the introduction of lower-cost prescription drug alternatives. The report summarizes data on patent settlements filed with the FTC and the Department […]
A process which involves removal of a stem cell from a human embryo at the blastocyst stage, entailing the destruction of that embryo, cannot be patented. Last week the Court of Justice of the European Union issued a judgment in the case of Brüstle v Greenpeace e.V (Case C 34/10) in which it banned the […]
As part of our Supporting Sponsorship of the BioOhio Annual Conference: 2020 Vision, we have one complimentary registration to share. Just be the first person to send us your name and email address by 5:00 pm EST tomorrow, Oct. 19th, and we’ll get your registration fee taken care of on us! We think that’s pretty […]
The UK Patents Court invalidated patent claims to an enantiomer of a known racemate mixture in Generics Ltd. V. Novartis AG [2011] EWHC 2403 (Pat). Generics (UK) Ltd. (Mylan) filed an action to try to invalidate a Supplementary Protection Certificate (“SPC”) for a drug for the treatment of Alzheimer’s disease called rivastigmine. An SPC extends […]
“The major issue in patent litigation in the People’s Republic of China is obtaining evidence to prove infringement.” ~ Douglas Clark As China’s economy has risen to be one of the largest in the world, disputes involving intellectual property rights will become more frequent as well as increasingly critical for business survival. “Patent Litigation in […]
The United States along with Australia, Canada, the European Union and its member states, Japan, South Korea, Mexico, Morocco, New Zealand, Singapore, and Switzerland reaffirmed their commitment to the Anti-Counterfeiting Trade Agreement (ACTA) at a signing ceremony in Tokyo. The agreement is meant to fight against the infringement of intellectual property rights (IPR), in particular […]
“Inevitably, the right to health comes into contradiction with patents on pharmaceutical products, which block the passage of a new medicine to the status of generic medicine.” “Development and Health In Poor Countries, The Role of International Organizations and of Switzerland,” by Bastien Briand et al. (Centrale Sanitaire Suisse Romande 2010; 224 pp.), presents the […]
Served Up Daily
Editor-in-Chief Barista Stephen Jenei is a patent attorney and Owner of Jenei LLC. When not serving up patent chat over a steaming cup of java, he's handling a diverse intellectual property practice in the biotechnology, pharmaceutical and chemical fields. More info @ Jenei LLC
